Firdapse

Active Ingredient(s): Amifampridine
FDA Approved: * November 28, 2018
Pharm Company: * CATALYST PHARMA INC
Category: Immune System

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Firdapse Overview

Amifampridine is used as a drug, predominantly in the treatment of a number of rare muscle diseases. The free base form of the drug has been used to treat congenital myasthenic syndromes and Lambert–Eaton myasthenic syndrome (LEMS) through compassionate use programs since the 1990s and was recommended as a first line treatment for LEMS in 2006, using ad hoc forms of the drug, since there was no marketed form. Around 2000 doctors at Assistance Publique – Hôpitaux de Paris crea...

Read more Firdapse Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Amifampridine

Recent Firdapse Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Amifampridine
  • Tablet: 10mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Firdapse: (1 result)

Sorted by National Drug Code
  • 69616-211 Firdapse 10 mg Oral Tablet by Catalyst Pharmaceuticals, Inc.

Other drugs which contain Amifampridine or a similar ingredient: (2 results)